Los análisis de sangre tienen un papel muy pequeño en la evaluación de la Morfea, aunque las. La esclerosis sistémica (escleroderma) es una enfermedad autoinmune del tejido conectivo .. artículo sobre un caso de morfea en una paciente de 24 años . Enfermedad pulmonar intersticial en esclerosis sistémica progresiva . Escleroderma localizada. Morfea. Morfea en placas. Morfea generalizada. Lineal .

Author: Darisar Migis
Country: Uruguay
Language: English (Spanish)
Genre: Business
Published (Last): 28 July 2011
Pages: 383
PDF File Size: 5.87 Mb
ePub File Size: 2.85 Mb
ISBN: 808-3-19039-713-4
Downloads: 67415
Price: Free* [*Free Regsitration Required]
Uploader: Nataxe

Are you a health professional able to prescribe or esclerosi drugs? Esclerodermia morfea in the series described, neurological involvement was more prevalent in patients with lesions on the esclerodermia morfea. With certain exceptions, the disorder does not have serious systemic repercussions, but it can cause considerable morbidity.

The following morbidities were morfex during follow-up: Morphea or localized scleroderma is a distinctive inflammatory disease that leads to sclerosis of the skin and subcutaneous tissues. Phototherapy has been used as adjuvant therapy due to its antifibrotic and immunosuppressive effect.

To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. This form of scleroderma showed an important rate of esthetic alterations and growth disorders, as well as a longer time of latency between the onset of the symptoms and the diagnosis. October Pages The selection criteria were all patients who completed at least one year of evolution of the disease and minimum 6 months of follow-up.

Morfea en coup de sabre. Eleven patients developed another autoimmune disease during follow-up Multiple lesions were present in esclerodermia morfea Existe evidencia de que la ciclofosfamida es eficaz en el tratamiento esclerodermia eslerosis la enfermedad pulmonar intersticial en pacientes con esclerodermia.


Morphea discriminates from systemic sclerosis by its supposed lack of internal organ involvement. Subscriber If you already have your login data, please click here. Print Send to a friend Export reference Mendeley Statistics. A greater extra-cutaneous involvement has been reported in juvenile patients compared with adults. Si continua navegando, consideramos que acepta su uso.

The esclerodermia morfea morbidity is accompanied by a negative and permanent impact on the quality escclerosis life of the patients with a diagnosis esclerrodermia jLS. In the case of lesions affecting the head, neurological and ocular complications may occur. Localized scleroderma Localized morphea Morphea—lichen sclerosus et atrophicus overlap Generalized morphea Atrophoderma of Pasini and Pierini Pansclerotic morphea Morphea profunda Esclerosia scleroderma.

Systemic scleroderma is characterized by esclerodermia morfea of internal organs and a worse esclerodermia morfea.

The mean age at the onset esclerodermia morfea the disease was 7.

The mixed involvement was the most frequent in 4 of 6 patients with growth alterations, followed by the longitudinal. It was characterized by being esclerofermia most severe esclerodernia progressive form that caused important esthetic and functional commitment.


To describe the clinical characteristics, morbidity and eaclerosis in patients with juvenile localized scleroderma in different pediatric rheumatology clinics in Colombia. Introduction Scleroderma is an autoimmune, polymorphic disease, mirfea by the presence of cutaneous sclerosis secondary to the excessive accumulation of collagen.

However, classification is difficult because the boundaries between the different types of morphea are blurred and different entities frequently overlap. Morphea en coup de sabre. There is no really effective and universal treatment so it is important to make a correct assessment of the extent and severity of the disease before deciding on a treatment approach.


However, classification is difficult because the boundaries between the different types of morphea are blurred and different entities frequently overlap.


The other esclerodermia morfea of localized scleroderma require a combined management with systemic corticosteroids and disease-modifying anti-rheumatic drugs DMARDsfor a minimum of 24 months to reduce the risk of relapse. Other drugs such as intravenous immunoglobulin, infliximab, rituximab, cyclosporine and dapsone esclerodermia morfea been used in refractory cases with variable responses. CiteScore measures average citations received per document published. Subscribe to our Newsletter.

In other projects Wikimedia Commons. Medias this blog was made to help people to easily download or read PDF files. Disease recurrence in localized scleroderma: Presence of polyautoimmunity according to the types and subtypes esclerodermia morfea scleroderma.

Hashimoto, et tence of generalizad morphea with histological changes in lichen sclerosus et atrophicus and lichen planus. La morfea o esclerodermia localizada es una enfermedad inflamatoria distintiva que conduce a la esclerosis de la piel y los tejidos subyacentes.

Results The study included 88 patients, with a gender distribution of female 2. esclerosls

There is no really effective and universal treatment so it is important to make a correct assessment of the extent and severity of morfwa disease before deciding on a treatment approach. One esclerodermia morfea them with localized scleroderma, vitiligo and psoriasis, confirmed by biopsy in that order of appearance.